Introducing Hepaxa™

The first product designed to support
patients with NAFLD.

The reduction of liver fat (in people with NAFLD) has a powerful effect on Type-2 Diabetes (T2D), glycemic control and hypertension.5

NAFLD can be reversed.

If NAFLD is addressed early, with adjustment to diet and exercise, many people can naturally reverse their liver fat composition to less than 5%. Doing so, can restore their natural liver function and help to improve their overall health.

However, many NAFLD patients have tried to make lifestyle changes and not been successful. In these cases, doctors want to help. Clinical studies have shown that daily use of polyunsaturated fatty acids (PUFA) like Hepaxa™ can reduce liver fat and in time reverse steatosis in NAFLD. Hepaxa™ is designed to help the dietary management of steatosis in NAFLD patients.

“Steatosis is now considered the initial step in a pathway that leads to advanced liver disease…”2

“A partial and temporary reduction in steatosis is associated with improved health outcomes (T2D) over a 10 year period.4

NAFLD in the United States

Fatty Liver disease has become an epidemic. The correct term is non-alcoholic fatty liver disease or NAFLD and the growth rate for the number of people being diagnosed has doubled in the past generation. NAFLD isn’t the only health concern that most of these patients are managing. The start of this problem is being overweight or obese. In fact, it has been reported that up to 75% of obese patients have some degree of NAFLD and that is not the only concern.  Most patients with NAFLD have also been diagnosed as Type-2 Diabetics, or with Metabolic Syndrome, or all three conditions. As recently as 2012, it is estimated that one-third of all American adults have some degree of NAFLD.

What is NAFLD?

As your doctor may have informed you, the liver is designed to process fat. With NAFLD, the liver begins to store fat. This decreases the ability for the liver to properly function. When a person has more than 5% liver fat composition, they are diagnosed with NAFLD. This process of storing excess liver fat is also called steatosis. Over time, steatosis can lead to more serious forms of the disease including Non-Alcoholic Steatohepatitis (NASH) and cirrhosis. NAFLD can also increase your risk of cardiovascular events and other complications.

References:
2) McPherson, S., et.Al, Journal of Hepatology 2015 vol. 62 j 1148–1155
4) Yamazaki, H., et.Al, Diabetes Care 2015;38:1673–1679
5) Peters et al, Journal of Nutritional Science, 2017, vol. 6, e15